CoChat

Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts

Open access
Secchiero, Paola, Zorzet, Sonia, Tripodo, Claudio, Corallini, Federica, Melloni, Elisabetta, Caruso, Lorenzo, Bosco, Raffaella, Ingrao, Sabrina, Zavan, Barbara, Zauli, Giorgio · 2010 · PLoS ONE
Cited by 148

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. METHODOLOGY/PRINCIPAL FINDINGS: The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV(-) Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV(+) B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) injection of MSC (4 days after i.p. injection of lymphoma cells) significantly increased the overall survival at an optimal MSC:lymphoma ratio of 1:10 in both xenograft models (BJAB+MSC, median survival = 58.5 days; SKW6.4+MSC, median survival = 40 days). Upon MSC injection, i.p. tumor masses developed more slowly and, at the histopathological observation, exhibited a massive stromal infiltration coupled to extensive intra-tumor necrosis. In in vitro experiments, we found that: i) MSC/lymphoma co-cultures modestly affected lymphoma cell survival and were characterized by increased release of pro-angiogenic cytokines with respect to the MSC, or lymphoma, cultures; ii) MSC induce the migration of endothelial cells in transwell assays, but promoted endothelial cell apoptosis in direct MSC/endothelial cell co-cultures. CONCLUSIONS/SIGNIFICANCE: Our data demonstrate that BM-MSC exhibit anti-lymphoma activity in two distinct xenograft SCID mouse models of disseminated NHL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0011140

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 28

  1. CA Clarke, 2002, Changing incidence of non-Hodgkin lymphomas in the United States., Cancer, 94, 2015, 10.1002/cncr.10403 · DOI · Paper page
  2. JO Armitage, 1998, New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes: Non-Hodgkin's Lymphoma classification project., J Clin Oncol, 16, 2780, 10.1200/JCO.1998.16.8.2780 · DOI · Paper page
  3. R Taub, 1982, Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells., Proc Natl Acad Sci U S A, 79, 7837, 10.1073/pnas.79.24.7837 · DOI · Paper page
  4. NA Bhowmick, 2004, Stromal fibroblasts in cancer initiation and progression., Nature, 432, 332, 10.1038/nature03096 · DOI · Paper page
  5. NE Kaya, 2007, Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch.”, Leuk Res, 31, 899, 10.1016/j.leukres.2006.11.024 · doi:10.1016/j.leukres.2006.11.024
  6. J Edelmann, 2008, Bone marrow fibroblasts induce expression of PI3K/NF-kB pathway genes and a pro-angiogenic phenotype in CLL cells., Leuk Res, 32, 1565, 10.1016/j.leukres.2008.03.003 · DOI
  7. H Ning, 2008, The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study., Leukemia, 22, 593, 10.1038/sj.leu.2405090 · DOI · Paper page
  8. S Iwamoto, 2007, Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase., J Clin Invest, 117, 1049, 10.1172/JCI30235 · DOI · Paper page
  9. I Guest, 2009, Direct and indirect contribution of bone marrow derived cells to cancer., Int J Cancer
  10. H Hamada, 2005, Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy., Cancer Sci, 96, 149, 10.1111/j.1349-7006.2005.00032.x · DOI · Paper page
  11. M Studeny, 2004, Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents., J Natl Cancer Inst, 96, 1593, 10.1093/jnci/djh299 · DOI · Paper page
  12. P Au, 2008, Bone marrow derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature., Blood, 111, 4551, 10.1182/blood-2007-10-118273 · DOI · Paper page
  13. T Sato, 2004, Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases., Gynecol Oncol, 92, 47, 10.1016/j.ygyno.2003.09.012 · DOI
  14. P Amé-Thomas, 2007, Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis., Blood, 109, 693, 10.1182/blood-2006-05-020800 · DOI · Paper page
  15. T Lwin, 2007, Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kB (RelB/p52) in non-Hodgkin's lymphoma cells., Leukemia, 21, 1521, 10.1038/sj.leu.2404723 · DOI
  16. C Dierks, 2007, Essential role of stromally induced hedgehog signaling in B-cell malignancies., Nature Med, 13, 944, 10.1038/nm1614 · DOI · Paper page
  17. J Ruan, 2006, Magnitude of stromal hemangiogenesis correlates with histologic subtype of Non-Hodgkin's lymphoma., Clin Cancer Res, 12, 5622, 10.1158/1078-0432.CCR-06-1204 · DOI · Paper page
  18. DA Chan, 2009, Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment., Cancer Cell, 15, 527, 10.1016/j.ccr.2009.04.010 · DOI · Paper page
  19. YB Choi, 2010, Induction of angiogenic chemokine CCL2 by human herpesvirus 8., Virology, 397, 369, 10.1016/j.virol.2009.11.024 · DOI
  20. R Trouillon, 2010, Angiogenin induces nitric oxide synthesis in endothelial cells through PI-3 and Akt kinases., Biochemistry, 49, 3282, 10.1021/bi902122w · DOI
  21. A De Becker, 2007, Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3., Haematologica, 92, 440, 10.3324/haematol.10475 · DOI · Paper page
  22. Y Zhu, 2009, Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1., Leukemia, 23, 925, 10.1038/leu.2008.384 · DOI · Paper page
  23. K Otsu, 2009, Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells., Blood, 113, 4197, 10.1182/blood-2008-09-176198 · DOI · Paper page
  24. G Lazennec, 2008, Concise Review: Adult multipotent stromal cells and cancer: risk or benefit?, Stem Cells, 26, 1387, 10.1634/stemcells.2007-1006 · DOI · Paper page
  25. FC Marini, 2009, The complex love-hate relationship between mesenchymal stromal cells and tumors., Cytotherapy, 11, 375, 10.1080/14653240903098195 · doi:10.1080/14653240903098195
  26. P Secchiero, 2005, TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release., Blood, 105, 3413, 10.1182/blood-2004-10-4111 · DOI · Paper page
  27. P Secchiero, 2007, Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells., Curr Drug Metab, 8, 395, 10.2174/138920007780655432 · DOI
  28. P Secchiero, 2004, TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells., Cell Mol Life Sci, 61, 1965, 10.1007/s00018-004-4197-6 · DOI

Cited by

See all 148

Metadata

Authors
Secchiero, P., Zorzet, S., Tripodo, C., Corallini, F., Melloni, E., Caruso, L., Bosco, R., Ingrao, S., Zavan, B., & Zauli, G.
Venue
PLoS ONE
Published
2010-06-16
Volume
5
Issue
6
Pages
e11140
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2062465944
Cited by
148
References
11
FWCI
5.57
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts. https://app.cochat.ai/papers/10.1371/journal.pone.0011140
The paper
Secchiero, P., Zorzet, S., Tripodo, C., Corallini, F., Melloni, E., Caruso, L., Bosco, R., Ingrao, S., Zavan, B., & Zauli, G. (2010). Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts. PLoS ONE. https://doi.org/10.1371/journal.pone.0011140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.